Please use this identifier to cite or link to this item: https://doi.org/10.1074/jbc.M113.522847
Title: Ceramides and glucosylceramides are independent antagonists of insulin signaling
Authors: Chavez, J.A.
Siddique, M.M. 
Wang, S.T.
Ching, J.
Shayman, J.A.
Summers, S.A.
Issue Date: 10-Jan-2014
Source: Chavez, J.A., Siddique, M.M., Wang, S.T., Ching, J., Shayman, J.A., Summers, S.A. (2014-01-10). Ceramides and glucosylceramides are independent antagonists of insulin signaling. Journal of Biological Chemistry 289 (2) : 723-734. ScholarBank@NUS Repository. https://doi.org/10.1074/jbc.M113.522847
Abstract: Background: Both ceramides and glucosylceramides have been implicated in the pathogenesis of insulin resistance. Results: These two classes of sphingolipids modulate insulin action but differ by both tissue specificity and mechanism of action. Conclusion: Ceramides and glucosylceramides are independent and separable antagonists of insulin signaling. Significance: These observations will contribute to our understanding of how sphingolipids contribute to obesity-related metabolic diseases. © 2014 by The American Society for Biochemistry and Molecular Biology, Inc.
Source Title: Journal of Biological Chemistry
URI: http://scholarbank.nus.edu.sg/handle/10635/110500
ISSN: 00219258
DOI: 10.1074/jbc.M113.522847
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

33
checked on Feb 19, 2018

WEB OF SCIENCETM
Citations

29
checked on Feb 19, 2018

Page view(s)

44
checked on Feb 18, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.